Cargando…

Cladribine/hydroxychloroquine: COVID-19-pneumonia, lymphopenia and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546922/ http://dx.doi.org/10.1007/s40278-020-84319-2

Ejemplares similares

Cladribine: Lymphopenia: case report
Publicado: (2021)

Cladribine: Lymphopenia: 2 case reports
Publicado: (2020)

Alemtuzumab/cladribine/natalizumab: Lymphopenia and COVID-19 infection: case report
Publicado: (2021)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Dexamethasone/hydroxychloroquine: Reactivation of COVID-19 infection and off label use: 4 case reports
Publicado: (2021)

Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
por: Mateo-Casas, M., et al.
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Hypoglycaemia following off-label use: 3 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Methemoglobinemia following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Cardiac toxicity following off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Hypoglycaemia and off label use: case report
Publicado: (2021)

Hydroxychloroquine: Retinal detachment while off label use: case report
Publicado: (2021)

Hydroxychloroquine/lopinavir/ritonavir: Bradycardia and off-label-use: case report
Publicado: (2021)

Hydroxychloroquine: Lack of efficacy following an off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Liver damage following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Acetylcysteine/hydroxychloroquine: Haemolysis and inflammation following off-label use of hydroxychloroquine and acetylcysteine: 7 case reports
Publicado: (2020)

Azithromycin/hydroxychloroquine: Ventricular arrhythmias following off-label use in COVID-19: 2 case reports
Publicado: (2020)

Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020)

Fingolimod: Lymphopenia and COVID-19 infection complicated by pneumonia: case report
Publicado: (2020)

Anti-bacterial/heparin/hydroxychloroquine: Off label use and resistance: case report.
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Hydroxychloroquine: AV nodal reentry tachycardia and off label use: case report
Publicado: (2020)

Hydroxychloroquine: Ocular myasthenic syndrome following off-label use: case report
Publicado: (2020)

Hydroxychloroquine/oseltamivir: Exacerbation of psoriasis during off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: DRESS syndrome following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Acute haemolytic anaemia following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Aggravation of myasthenia gravis following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Cardiac disorder followed by off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Various toxicities secondary to off label use: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Hydroxychloroquine: Elevated aminotransferase levels following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sf0bdcr1otkife73ulvmlj7vbh